oxybutynin + antibiotics

The combination of oxybutynin and standard antimicrobial (antibiotic) therapy is an adjunctive treatment strategy investigated for the management of pediatric cystitis. Oxybutynin is a small molecule anticholinergic agent that acts as a bladder antispasmodic by antagonizing muscarinic receptors in the bladder wall, thereby reducing detrusor muscle spasms and associated symptoms such as pain, urgency, and frequency. In this therapeutic approach, oxybutynin is administered alongside standard-of-care antibiotics to address both the underlying bacterial infection and the symptomatic bladder irritation. This specific combination was the subject of a randomized, double-blind, placebo-controlled clinical trial conducted by the University of Calgary, which evaluated the efficacy of oral oxybutynin syrup in reducing pain and discomfort in children aged 4 to 16 years with acute cystitis.

Other names

antibiotics-University of Calgary-cystitisoxybutynin as adjunctive therapy to standard antimicrobial treatmentoxybutynin + antimicrobial therapy